Pfizer Pursuing Innovation via New Biotherapeutics and Bioinnovation Center

Pfizer Pursuing Innovation via New Biotherapeutics and Bioinnovation Center

November 7, 2007--Corey Goodman, co-founder of biopharmaceutical companies Renovis and Exelixis, has made the leap from biotech to big pharma, having recently taken the helm of Pfizer’s new Biotherapeutics and Bioinnovation Center. Threatened by generic competition (half a dozen of Pfizer's blockbuster drugs have either recently gone off patent or soon will), Goodman’s South San Francisco center is under pressure to form collaborations with biotech companies that will bear new drugs to bolster Pfizer’s pipeline. Goodman hopes to create an independent, entrepreneurial science outfit that will help Pfizer build a product line of biologic drugs. San Francisco Chronicle

Click here to log in.


Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Content Analyst Company
Using Cloud-Based Discovery Support
Sponsored by Content Analyst Company

Life Science Webcasts & Podcasts

medidata_podcast_Sites and Sponsors: Mending Bridges over Troubled Waters  
Sites and Sponsors: Mending Bridges over Troubled Waters
Sponsored by Medidata Solutions Worldwide

This podcast brings together two industry leaders to focus on the issues that divide sponsors and sites. On the one hand sites and sponsors unite in advancing better health care through a common passion for developing better drugs. Yet some issues divide them and bridges need to be built or mended to advance the highest levels of cooperation, coordination and success in clinical trials. Listen as the key issues are debated from the site and the sponsor side and new methods and technology are advanced that offer near-term and lasting solutions.

• Common ground in reaching agreement on a budget

• Improving the pace of agreement on budgets and contracts

• Processes for payment to sites on a timely basis

Listen Now  

More Podcasts

Job Openings

For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 ,